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The Saccharomyces cerevisiae CLN3 protein, a G1 cyclin, positively regulates the expression of CLN1 and
CLN2, two additional G1 cyclins whose expression during late G1 is activated, in part, by the transcription
factors SWI4 and SWI6. We isolated 12 complementation groups of mutants that require CLN3. The members
of one of these complementation groups have mutations in the BCK2 gene. In a wild-type CLN3 genetic
background, bck2mutants have a normal growth rate but have a larger cell size, are more sensitive to a-factor,
and have a modest defect in the accumulation of CLN1 and CLN2 RNA. In the absence of CLN3, bck2mutations
cause an extremely slow growth rate: the cells accumulate in late G1 with very low levels of CLN1 and CLN2
RNA. The slow growth rate and long G1 delay of bck2 cln3 mutants are cured by heterologous expression of
CLN2. Moreover, overexpression of BCK2 induces very high levels of CLN1, CLN2, and HCS26 RNAs. The
results suggest that BCK2 and CLN3 provide parallel activation pathways for the expression of CLN1 and
CLN2 during late G1.
The Saccharomyces cerevisiae CLN1, CLN2, and CLN3
genes encode G1 cyclins that interact with the CDC28 protein
to form complexes with kinase activity (8, 21, 29, 33, 40). A
sufficient level of CLN/CDC28 kinase activity is required dur-
ing the late G1 stage of the cell cycle for the execution of Start.
Prior to the execution of Start, nutrient limitation or the pres-
ence of mating pheromones can arrest the cells in G1. Once a
cell has executed Start, nutrient limitation and mating phero-
mones do not prevent cell cycle progression (until the follow-
ing G1), and the cells are committed to divide.
In early G1, the cells have very low levels of CLN1 and CLN2
RNAs. During late G1, the levels of CLN1 and CLN2 RNAs
increase dramatically (42). A large fraction of the late G1
transcription of CLN1 and CLN2 is activated by the SWI4 and
SWI6 transcription factors, which bind as a complex to sites in
the CLN1 and CLN2 promoters (3, 30, 31). In addition, ex-
pression of normal levels of CLN1 and CLN2 during late G1
requires the function of the CDC28 kinase and the function of
at least one of the three CLN genes (CLN1, CLN2, or CLN3)
(11, 15). These results have suggested that the accumulation of
CLN1 and CLN2 RNAs during late G1 requires CLN-associ-
ated kinase activity. It is currently not known what substrate(s)
requires phosphorylation by the CLN-associated kinase for
CLN1 and CLN2 RNA accumulation during late G1.
In addition to the CDC28 and CLN genes, the SIT4 serine/
threonine protein phosphatase is also required for the normal
accumulation of CLN1 and CLN2 RNAs during late G1 (19,
37). By contrast, SIT4 is not required for normal levels of
CLN3 RNA. During late G1, the SWI4 RNA levels increase
dramatically and reach their peak just prior to or at the time
when CLN1 and CLN2 RNA levels reach their peak (5, 19).
The requirement for SIT4 for the normal accumulation of
CLN1 and CLN2 RNAs during late G1 is at least partly due to
the requirement for SIT4 for the normal increase in SWI4
RNA levels during late G1 (19).
CLN3 can regulate the rate of accumulation of CLN1 and
CLN2 RNAs (8, 11, 15, 29). The dominant CLN3-1 and
CLN3-2 alleles encode hyperactive forms of CLN3 that in-
crease the rate of CLN1 and CLN2 RNA accumulation during
late G1. Such cells initiate Start at a smaller than normal
critical cell volume and are relatively resistant to a-factor. By
contrast, deletion of CLN3 results in a slower than normal rate
of accumulation of CLN1 and CLN2 RNAs during late G1.
The Dcln3 cells initiate Start at a larger than normal critical cell
volume and are more sensitive to a-factor than are wild-type
cells. Because the CLN3 protein is unstable (9, 40), the levels
of the CLN3 protein might be sensitive to the rate of protein
synthesis. Therefore, CLN3 (along with possible additional
factors) may set the timing of Start relative to the growth rate
of the cell.
The CLN3 gene is normally dispensable, and Dcln3 cells
have a normal growth rate (8, 29). However, the defect in
CLN1 and CLN2 RNA accumulation resulting from the ab-
sence of CLN3 becomes apparent when a cln3 mutation is
combined with an additional mutation in a gene that also
functions for normal CLN1 and CLN2 RNA accumulation.
For instance, Dswi4 cells have a slow-growth phenotype that is
primarily due to a defect in CLN1 and CLN2 RNA accumu-
lation (30, 31). Combining a swi4 mutation with a cln3 muta-
tion results in a very slow growth rate that is partially cured by
high-copy-number CLN2 (30) or cured by heterologous ex-
pression of CLN2 (3a). Likewise, sit4 mutants have a defect in
SWI4, CLN1, and CLN2 RNA accumulation. Combining a sit4
mutation with a cln3 mutation results in near lethality. The
near lethality of sit4 cln3 strains is due to a defect in CLN2
(and probably CLN1) RNA accumulation because the syn-
thetic growth rate defect is completely cured by expressing
CLN2 at near wild-type levels from a SIT4-independent pro-
moter (19).
To identify possible targets of the SIT4 phosphatase that
function for the expression of CLN1 and CLN2, we isolated
mutants that (like sit4 mutants) require CLN3 for either via-
bility or a normal growth rate. The members of one comple-
mentation group of these mutants have mutations in the BCK2
gene. The BCK2 gene was originally isolated as a gene that in
high copy number can suppress the temperature-sensitive cell
lysis defect of mutations in the protein kinase C pathway (24).
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More recently, BCK2 was isolated as a suppressor of a cln1 cln2
cln3 strain (18, 20a). Epstein and Cross (18) found that bck2
cells are dramatically impaired in their growth rate if they also
lack CLN3. Moreover, these authors found that transcription
of a CLN2 reporter construct in cells arrested in G1 because of
the lack of CLN function (which gives low levels of CLN2
RNA) is about 8.5-fold further reduced in bck2 cells compared
with BCK2 cells. Here we show that, in the absence of CLN3,
BCK2 is required for CLN1 and CLN2 RNA accumulation
during G1. Moreover, overexpression of BCK2 causes a large
increase in the levels of CLN1 and CLN2 RNAs. Genetic
interactions between Dbck2, Dsit4, and Dcln3 mutations sug-
gest a model whereby BCK2 and SIT4 function in a pathway
that activates CLN1 and CLN2 expression in parallel with the
CLN3 pathway.
MATERIALS AND METHODS
Yeast strains and media. Yeast strains used are listed in Table 1. Yeast cells
were grown on either YPD medium (1% yeast extract, 2% peptone, and 2%
glucose) or synthetic complete (SC) medium (using, per liter, 0.2 g of leucine and
0.1 g of all other amino acids, 0.1 g of uracil, and 0.075 g of adenine, with the
indicated carbon source) (35). For plasmid selection, the appropriate amino acid
or uracil was omitted from the SC medium.
Isolation of ctr mutants. We prepared MATa and MATa Dcln3::HIS3 SSD1-v
ade2 ade3 ura3 strains that contained the CLN3 gene on an ADE3/URA3 cen-
tromere plasmid (CY2446 and CY2932; Table 1). When these cells contain the
CLN3/ADE3/URA3 plasmid, they accumulate a red pigment. Cells that have lost
the CLN3/ADE3/URA3 plasmid do not accumulate the red pigment. Strains
CY2446 and CY2932, which do not require CLN3, form red colonies with many
white sectors composed of cells that have lost the CLN3/ADE3/URA3 plasmid.
Also, when replica plated onto 5-fluoro-orotic acid (5-FOA) medium, which
allows only Ura2 cells to grow (4), these colonies give rise to a confluent patch
of cells because they contain many Ura2 segregants that are able to grow with a
normal growth rate. If these starting strains also contain a mutation that causes
CLN3 to be essential, they will give rise to solid red colonies (all viable cells
contain the CLN3/ADE3/URA3 plasmid) where none of the cells are able to grow
when replica plated onto 5-FOA medium. Strains CY2446 and CY2932 were
mutagenized to 30% survival with ethyl methylsulfonate and plated for single
colonies. From about 80,000 MATa and 80,000 MATa colonies, we obtained
about 400 nonsectoring 5-FOA-negative (Foa2) colonies. Of these 400 putative
ctr strains, 114 were placed into 12 complementation groups, using the sectoring
and Foa phenotypes.
CTR7 is the same gene as BCK2. A ctr7-263 pGAL:CLN3 strain was grown on
galactose medium and transformed with a YCp50 library containing yeast
genomic inserts (34). Two groups of plasmid complemented the slow-growth-rate
phenotype of the ctr7-263 pGAL:CLN3 strain grown on glucose. One class of
plasmid contained the wild-type CLN3 gene. The other class of plasmid con-
tained the authentic CTR7 gene: a LEU2 marker at the chromosomal locus
corresponding to the cloned DNA was 100% linked to ctr7 in 40 tetrads.
The location of the CTR7 gene within the yeast DNA sequences was deter-
mined by subcloning and complementation analysis. A 3.3-kb NsiI fragment,
which gave full ctr7 complementation, contained sequences from about 2550 to
12776 of the BCK2 gene (24). BCK2 coding sequences are from 11 to 12555,
all numbers relative to the A of the BCK2 putative ATG start codon. Frameshift
mutations within BCK2 coding sequences eliminated complementation.
Deletion alleles. The Dcln3 mutation replaces CLN3 DNA sequences between
the BstXI and EcoRI sites (removes DNA sequences encoding amino acids 1
through 387, of 581 total amino acids) with either a 1.2-kb HindIII URA3
fragment, a 2.2-kb XhoI-SalI LEU2 fragment, or a 1.8-kb BamHI HIS3 fragment.
The Dbck2::TRP1 mutation, obtained from D. Levin, removes DNA sequences
coding for amino acids 338 through 693 of BCK2 (of 851 total amino acids) and
replaces them with two tandem copies of the TRP1 gene (24). The isogenic
wild-type, Dswi4, and Dswi6 strains were obtained from J. Ogas and B. Andrews
and are described in references 31 and 41.
Expression of BCK2 from the GAL1 promoter.Using oligonucleotide-directed
mutagenesis, we created an XbaI restriction site 23 bp upstream of the A of the
predicted BCK2 ATG initiation codon. This XbaI site was used to place BCK2
coding sequences under control of the GAL1 promoter in either a YCp50 or a
LEU2/cen expression plasmid.
CLN2 promoter deletions. The 2.5-kb NruI-ClaI fragment containing CLN2
that encodes a CLN2 protein with a triple hemagglutinin epitope tag at the
carboxyl terminus, CLN2C in reference 39, was blunted into the SmaI and AccI
sites of pUC118, yielding plasmid pCB1321. Oligonucleotide-directed mutagen-
esis was used to remove positions2499 to2403 for deletion CC, positions2409
to2318 for deletion DD, or positions2318 to2259 for deletion EE and replace
them with a 6-bp XhoI site. KpnI-PstI fragments containing CLN2 (for AA, CC,
DD, or EE) or a SphI-PstI fragment containing CLN2 (for BB) were blunted into
the HindIII site of LEU2/cen plasmid pAB484 (constructed by replacing the
SalI-SmaI URA3-containing fragment of YCp50 with the 2.2-kb XhoI-SalI frag-
ment containing LEU2). For orientation 1, the CLN2-containing fragment is
oriented so that the CLN2 stop codon is closer to the LEU2 gene, while for
orientation 2, the CLN2 promoter is closer to the LEU2 gene.
Northern (RNA) analysis and probes. Total RNA was loaded onto a 1%
agarose gel containing 6% formaldehyde, 0.02 M morpholinopropanesulfonic
acid, 0.005 M sodium acetate, and 0.001 M EDTA (pH 7.0). The gels were
blotted onto BioTrans nylon membranes. The probes were the 1.4-kb ClaI-NotI
fragment of CLN1, the 0.75-kb XhoI-HindIII fragment of CLN2, the 0.6-kb AluI
fragment of ACT1, the 2.2-kb BamHI fragment of SWI4, the 0.5-kb EcoRI
fragment of CLB5, the 0.9-kb EcoRI-BamHI fragment of HCS26, the 2.4-kb
XbaI-NsiI fragment of MBP1, the 2.7-kb EcoRI fragment of RNR1, the 1.36-kb
HindIII-EcoRI fragment of BCK2, the 1.2-kbHindIII fragment of URA3, and the
2.0-kb HindIII-XhoI fragment of CLB2. The blots were washed twice (15 min
each) at 248C with 23 SSC (13 SSC is 0.15 M NaCl plus 0.015 M sodium
citrate)–0.1% sodium dodecyl sulfate (SDS) and then twice (15 min each) at
658C with 0.13 SSC–0.1% SDS.
TABLE 1. Yeast strains used
Strain Genotype Source or reference
AY925 MATa ura3-1 leu2-3,112 his3-11,15 trp1-1 ade2-1 ssd1-d2 can1-100 W303 of R. Rothstein
CY279 MATa Dsit4::HIS3 SSD1-v ura3 leu2 his3 trp1 37
CY2446 MATa Dcln3::HIS3 SSD1-v ura3-52 leu2 his3 trp1 ade2-101 ade3::HisG {CLN3/ADE3/YCp50} This study
CY2932 MATa Dcln3::HIS3 SSD1-v ura3-52 leu2 his3 lys2 ade2-101 ade3::HisG {CLN3/ADE3/YCp50} This study
CY3182 MATa/MATa Dmpk1::TRP1/2 ura3-52/2 leu2-3,112/2 his4/2 trp1-1/2 can1r/can1r homozygous
diploid
24
CY3276 MATa Dbck2::TRP1 SSD1-v ura3-52 leu2-3,112 his4 trp1-1 canr D. Levin
CY3317 CY3276 {BCK2/YCp50} This study
CY3319 CY3276 {YCp50} This study
CY3507 AY925 {pGAL:BCK2/YCp50} This study
CY3510 AY925 {YCp50/pGAL expression plasmid with no insert} This study
CY3557 MATa ssd1-d ura3-52 leu2D1 his3D200 ade2-101 lys2-801 plus SCB-lacZ at HIS3 locus B. Andrews
CY3582 MATa Dswi4::HIS3 in CY3557 background J. Ogas
CY3656 MATa Dswi6::HIS3 in CY3557 background B. Andrews
CY3779 MATa Dswi6::HIS3 ssd1-d ura3-52 leu2D1 his3D200 ade2-101 lys2-801 {2mm/URA3/MCB-lacZ} This study
CY3798 MATa ssd1-d ura3-52 leu2D1 his3D200 ade2-101 lys2-801 {2mm/URA3/MCB-lacZ} This study
CY4271 CY3507 plus Dcln2::TRP1 This study
DY79 MATa Dbck2::TRP1 pGAL:CLN3 (LEU2 marked, at CLN3 locus) ura3 leu2 his3 trp1 ade2 {YCp50} This study
DY80 MATa Dbck2::TRP1 pGAL:CLN3 (LEU2 marked, at CLN3 locus) ura3 leu2 his3 trp1 ade2 {BCK2/
YCp50}
This study
263 MATa ctr7-263 Dcln3::HIS3 SSD1-v ura3-52 leu2 his3 lys2 ade2-101 ade3::HisG
{CLN3/ADE3/YCp50}
This study
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b-Galactosidase assays. To exponentially growing cells (on either SC lacking
uracil [SC-uracil] 2% raffinose or SC-uracil,-leucine 2% raffinose medium) at an
optical density at 600 nm (OD600) of 0.2 to 0.25, galactose was added to 2% (final
concentration) at time zero. Cells were collected at the indicated times. Extracts
were prepared by vortexing the cells in breaking buffer (0.1 M Tris [pH 8.0], 20%
glycerol, 1 mM dithiothreitol, 1 mM phenylmethylsulfonyl fluoride) in the pres-
ence of glass beads and then centrifuging them for 10 min at 13,000 3 g to
remove cell debris. For the assays, 0.1 ml of extract was mixed with 0.9 ml of Z
buffer (0.1 M NaPO4 [pH 7.0], 0.01 M KCl, 1 mM MgSO4, 4 mM 2-mercapto-
ethanol) and incubated at 288C. After 5 min, 0.2 ml of o-nitrophenylgalactoside
(Sigma N-1127; at 4 mg/ml in Z buffer) solution was added. The reactions were
stopped by the addition of 0.5 ml of 1 M Na2CO3, and the A420 was determined.
b-Galactosidase units were calculated by the following formula: units 5
(A420)(377.8)/(time, in minutes)(volume of extract in assay 5 0.1 ml)(protein
concentration of extract, in milligrams per milliliter). For each time point, the
assays were performed on at least two separate equivalent cultures, and the
average is reported.
RESULTS
Isolation of BCK2 as a gene that is required in the absence
of CLN3. Because Dcln3 strains have a wild-type growth rate,
Dcln3 cells containing the CLN3 gene on a centromere plasmid
(a CLN3/ADE3/URA3 plasmid) grow at about the same rate as
Dcln3 cells. By contrast, if the Dcln3 {CLN3/ADE3/URA3 plas-
mid} cells have a mutation (ctr [cln three requiring]) that
causes CLN3 to be required for a normal growth rate, cells that
have lost the CLN3 plasmid will be inviable or grow very
slowly. Using the colony sectoring assay (23), we isolated about
400 ctr mutants (see Materials and Methods). Of the 400 pu-
tative ctr mutants, 114 were placed into 12 complementation
groups. The remainder of the putative ctr mutants either com-
plemented all ctrmutants of the opposite mating type (possible
unique mutants), did not complement any of the ctrmutants of
the opposite mating type (probably resulting from integration
of the CLN3/ADE3/URA3 plasmid), did not mate, or were
unstable during storage and propagation.
Another copy of the CLN3 gene (on a LEU2/cen plasmid)
was introduced into representative ctr1 through ctr10 mutants.
These mutants fell into one of three classes (Fig. 1A). For the
first class, containing only groups 7, 9, and 10, the CLN3/LEU2
plasmid transformants were able to grow at wild-type or near
wild-type rates in the absence of the CLN3/ADE3/URA3 plas-
mid (the strain background has a Dcln3 mutation). For the
second class, groups 1, 2, 5, 6, and 8, the CLN3/LEU2 plasmid
transformants grew better if they also had the CLN3/ADE3/
URA3 plasmid, which suggests that these mutants grow better
if they have two CLN3 genes. For the third class, groups 3 and
4, the CLN3/LEU2 plasmid transformants were able to grow
only very poorly in the absence of the CLN3/ADE3/URA3
plasmid.
The remainder of this report will focus on the ctr7 mutants.
The CTR7 gene was cloned and found to be identical to the
BCK2 gene (see Materials and Methods). We will now refer to
the ctr7 mutants as bck2 mutants. An extra copy of the wild-
type CLN2 gene did not increase the ability of the bck2 mu-
tants to grow in the absence of CLN3 (Fig. 1B). By contrast,
expression of CLN2 coding sequences from the Schizosaccha-
romyces pombe ADH promoter (S.p.ADH, which expresses
CLN2 at levels similar to the CLN2 levels in a wild-type strain
[data not shown]) or from the S. cerevisiae ADH promoter
(S.c.ADH, which gives 10- to 20-fold-higher levels of CLN2
[data not shown]) allowed the bck2 mutants to grow very well
in the absence of CLN3 (Fig. 1B). Related to these findings,
Epstein and Cross (18) found that high-level expression of
CLN1 from the GAL1 promoter can rescue the inviability of a
cln2 cln3 bck2 strain and that expression of CLN2 coding
sequences from the CLN3 promoter can partially rescue a cln1
cln3 bck2 strain. These findings suggest that bck2 mutants
cannot grow (or grow very slowly) in the absence of CLN3 is
because of a defect in the expression of CLN1 and CLN2 from
their normal promoters.
Like the CLN1 and CLN2RNA levels, the SWI4RNA levels
also peak in late G1. The periodic expression of SWI4 may be
required for the normal expression of CLN1 and CLN2 (5).
When the bck2 mutants contained an extra copy of wild-type
SWI4, there was a very slight increase in the ability to grow in
the absence of CLN3 (Fig. 1B). When SWI4 coding sequences
were transcribed from the S.p.ADH promoter (which gives
about 5- to 10-fold-higher levels of SWI4 RNA than from the
wild-type promoter [data not shown]), the bck2 mutants grew
reasonably well in the absence of CLN3 (Fig. 1B). Thus, over-
expression of SWI4 from a heterologous promoter can partially
suppress the slow growth rate of bck2 cln3 strains.
In the absence of CLN3, BCK2 is required for normal CLN1
and CLN2 expression. To determine the effect of a null allele
of BCK2 on the ability to grow in the absence of CLN3, we
obtained a Dbck2::TRP1 strain (CY3276) from D. Levin (24).
When the Dbck2 strain was crossed to a Dcln3 strain, viable
Dbck2 Dcln3 progeny were obtained, but they grew very slowly
(data not shown). These findings contrast with those of Epstein
and Cross (18), who reported that bck2 cln3 spores are invia-
ble. Perhaps strain background effects or their use of a bck2
FIG. 1. Ability of ctr strains to grow in the absence of CLN3. (A) Summary
of the ability of ctr1 through ctr10 strains to grow in the absence of CLN3 after
transformation with the indicated plasmid. We obtained 3 group 1, 14 group 2,
23 group 3, 13 group 4, 29 group 5, 8 group 6, 10 group 7, 5 group 8, 2 group 9,
3 group 10, 2 group 11, and 2 group 12 putative ctr mutants. 1, full or near full
wild-type ability; 1/2, partial ability; 2/1, slight ability; 2, no or almost no
ability to grow in the absence of CLN3. The ability of the strains to grow in the
absence of CLN3 was determined by both their sectoring and Foa phenotypes.
The ctr5 mutants may be swi4 mutants because they are complemented by the
wild-type SWI4 gene. SIT4 does not complement ctr1 through ctr10. (B) Trans-
formants of a ctr7-263 Dcln3 {CLN3/ADE3/URA3/cen plasmid} strain (strain
263) with the indicated LEU2/cen plasmids were streaked for single colonies on
a YPD plate and replica plated onto an SC plate containing 5-FOA (4), on which
only Ura2 (that is, without the CLN3-containing URA3/cen plasmid) cells can
grow. Growth is shown after 1.5 days at 308C. The S.p.ADH:CLN2, S.p.ADH:
SWI4, and S.c.ADH:CLN2 plasmids were described in reference 19. An inde-
pendent ctr7 mutant gave equivalent results. In all cases, the ability to give
sectored colonies corresponded to the ability to grow on 5-FOA medium.
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disruption allele accounts for these differences. Two hours
after glucose was added to a Dbck2 pGAL:CLN3 strain grow-
ing on galactose medium (which repressed pGAL:CLN3 ex-
pression), the culture became highly enriched in unbudded
uninucleate cells with a 1n DNA content (data not shown),
confirming the findings of Epstein and Cross (18). Moreover,
for the Dbck2 pGAL:CLN3 strain on glucose medium, heter-
ologous expression of CLN2 from the S.p.ADH promoter elim-
inated much of the long G1 delay and restored a near wild-type
growth rate, while heterologous expression of CLN2 from the
S.c.ADH promoter eliminated all of the G1 delay and gave a
wild-type growth rate (data not shown).
Previously, Epstein and Cross (18) showed that the RNA
levels of a CLN2 reporter in cells arrested in G1 due to the lack
of CLN function (conditions which give low CLN2 expression
because most CLN2 transcription requires CLN function [11,
15]) is about 8.5-fold lower in bck2 cells than in BCK2 cells. To
determine the rate and level of CLN1 and CLN2 RNA accu-
mulation during G1 in the absence BCK2 and CLN3 function
in an otherwise wild-type cell, we used the procedure described
in the legend to Fig. 2A. For the BCK2 pGAL:CLN3 cells
(effectively BCK2 cln3), the levels of CLN1, CLN2, SWI4, and
CLB5 RNAs increased and reached maximal levels at about 1
h after a-factor release (after which most of the cells formed a
bud) (Fig. 2A). This rate of increase for the CLN1, CLN2,
SWI4, and CLB5 RNA levels is somewhat slower than for
wild-type cells because of the absence of normal CLN3 func-
tion. By contrast, when the Dbck2 pGAL:CLN3 cells (effective-
ly bck2 cln3) were released from the a-factor arrest, the levels
of CLN1, CLN2, and CLB5 RNA remained very low and the
cells did not form a bud, even up to 72 min after the release
(Fig. 2A). The SWI4 RNA levels for the Dbck2 pGAL:CLN3
cells increased, but not quite to the levels as for the BCK2
pGAL:CLN3 cells. The very low CLN1 and CLN2 RNA accu-
mulation in bck2 cln3 cells, along with the finding that the long
G1 delay and the growth defect of bck2 cln3 cells is cured by
heterologous expression of CLN2, suggests that in the absence
of CLN3, BCK2 is most likely required for significant levels of
CLN1, CLN2, and CLB5 RNA accumulation. That the defect
in SWI4 RNA accumulation is relatively modest compared
with the very strong defects in CLN1 and CLN2 RNA accu-
mulation raises the possibility that bck2 cln3 cells are defective
in the ability of SWI4 to stimulate CLN1 and CLN2 RNA
accumulation (or alternatively in the expression of SWI4 pro-
tein from SWI4 RNA).
Effect of Dbck2 and high-copy-number BCK2 in the presence
of CLN3. In the presence of CLN3, deletion of BCK2 does not
result in any significant decrease in the growth rate of the cell
(18, 24). However, the absence of BCK2 caused a modest
decrease in the accumulation rate (peak levels were delayed
about 10 min) and a modest decrease in the peak levels of
CLN2 and HCS26 RNAs during late G1 (Fig. 2B). Therefore,
like the loss of CLN3 function in an otherwise wild-type strain,
deletion of BCK2 in an otherwise wild-type strain results in a
modest decrease in the rate and levels of CLN2 RNA accu-
mulation. In contrast to the CLN2 and HCS26 RNA levels, the
SWI4 RNA levels are more similar (and have about a 5-min
delay) in the Dbck2 strain compared with the wild-type strain,
suggesting that the ability of SWI4 to activate CLN2 expression
is partially defective in the absence of BCK2.
As a consequence of the alteration in CLN1 and CLN2RNA
accumulation, Dcln3 cells are more sensitive to a-factor and
initiate Start at a larger than normal cell volume. Moreover,
cells containing hyperactive alleles of CLN3 are more resistant
to a-factor and initiate Start at a smaller than normal cell
volume (8, 29). Therefore, we determined the a-factor sensi-
tivity and cell size of Dbck2, wild-type, and high-copy-number
BCK2 strains. The Dbck2 cells were more sensitive to a-factor,
while high-copy-number BCK2-containing cells were more re-
sistant to a factor (Fig. 3A). The increased sensitivity of Dbck2
cells to a-factor was due to a defect in CLN1 and CLN2 RNA
accumulation because expression of CLN2 coding sequences
from the S.p.ADH promoter restored normal a-factor sensitiv-
ity to the Dbck2 cells (data not shown). In addition, Dbck2 cells
also had a larger than normal cell volume (confirming the
findings of Epstein and Cross [18]), while high-copy-number
BCK2-containing cells had a slightly smaller than normal cell
volume (Fig. 3B). Together, these findings indicate that even in
the presence of CLN3, BCK2 has a role at Start.
Overexpression of BCK2 stimulates the expression of CLN1
and CLN2. The results presented above suggest that BCK2 and
CLN3 provide parallel activation pathways for the expression
of CLN1 and CLN2. Moreover, the BCK2 gene on a high-copy-
FIG. 2. Effect of BCK2 on CLN1 and CLN2 expression in the absence or
presence of CLN3. (A) The absence of CLN3. Strains DY79 (Dbck2 pGAL:CLN3
{YCp50}) and DY80 (Dbck2 pGAL:CLN3 {BCK2/YCp50}) were grown expo-
nentially at 308C in SC-uracil 2% galactose medium to an OD600 of 0.08. The
cells were arrested in G1 by addition of a-factor (to a final concentration of 0.012
mM), which represses CLN1 and CLN2 expression. After 2.75 h with a-factor,
the cells arrested in late G1 by the criteria of budding index, DNA content (flow
cytometry), and the presence of schmoo-shaped cells. Next, CLN3 expression
was repressed by addition of glucose to 2% (final concentration) (CLN3 RNA
and protein are unstable so that their levels decrease rapidly [9, 40]). After 0.5 h
in glucose, the cells were released from the a-factor arrest by filtering, washing,
and resuspending in fresh SC-uracil 2% glucose medium. All procedures were
performed in parallel for the two cultures. (B) The presence of CLN3. Isogenic
strains CY3317 (BCK2) and CY3319 (Dbck2) were grown exponentially in SC-
uracil 2% glucose medium at 308C to an OD600 of 0.22, at which time a-factor
was added to 0.01 mM (final concentration). After 2.5 h, the cells were released
(in parallel) from the a-factor arrest by filtering, washing, and resuspending in
fresh SC-uracil 2% glucose medium. For both panels, total RNA was prepared
from cells collected at the indicated times after the a-factor release; 5 mg of total
RNA was loaded onto each lane of a 1% agarose gel, and the Northern blots
were prepared as described in Materials and Methods.
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number plasmid stimulated the growth rate of a CLN1 Dcln2
Dcln3 strain (which has a moderate slow-growth phenotype
due to lower than normal levels of G1 cyclins [13]) and also
stimulated the slow growth rate of a Dswi4 strain (the slow
growth rate of Dswi4 strains is due to a defect in G1 cyclin
expression; see reference 31) (Table 2). In contrast, the slow
growth rate of a Dswi6 strain, which is not stimulated by low- or
high-level heterologous expression of CLN2 (data not shown),
is not stimulated by the BCK2 gene on a high-copy-number
plasmid (Table 2).
To look directly at the ability of overexpressed BCK2 to
activate transcription of CLN1 and CLN2, we prepared North-
ern blots with RNA isolated from a strain containing BCK2
coding sequences expressed from the GAL1 promoter (see
Materials and Methods). Twenty minutes after galactose was
added to a pGAL:BCK2 strain, the levels of BCK2 RNA in-
creased dramatically (Fig. 4A). The increase in BCK2 levels
subsequently (by 40 min) induced very high level expression of
CLN1 and CLN2 (whose promoters contain SWI4/SWI6-de-
pendent cell cycle box [SCB]-like and MluI-containing cell
cycle box [MCB]-like elements [10, 31, 36]) and CLB5 (whose
promoter contains MCB-like elements [17]) (Fig. 4A). Tran-
scription from SCB and MCB promoter elements is cell cycle
dependent and reaches maximal levels during late G1. The
increase in CLN1, CLN2, and CLB5 RNA levels by overex-
pressed BCK2 was not due to accumulation of the cells in G1,
as determined by the budding index and flow cytometry anal-
ysis of the cultures (data not shown). Interestingly, overexpres-
sion of BCK2 only slightly increased SWI4 RNA levels in this
strain (Fig. 4B and data not shown). Therefore, overexpression
of BCK2 can induce high-level accumulation of CLN1 and
CLN2 RNAs by a mechanism that does not require a large
increase in SWI4 transcription. Further demonstration of spec-
ificity in the ability of overexpressed BCK2 to induce high
levels of a given cell cycle-regulated RNA is the finding that
overexpressed BCK2 did not increase the levels of histone
HTA1 RNA (Fig. 4A).
Promoters containing multiple SCB or multiple MCB ele-
ments are activated about twofold by overexpression of BCK2.
Overexpression of BCK2 could increase CLN1 and CLN2
RNA levels either by increasing the rate of transcription or by
increasing the stability of the RNAs. Although overexpressed
BCK2 greatly increased CLN2 RNA levels when CLN2 was
expressed from the wild-type promoter, it had no effect when
FIG. 3. Phenotypes due to the absence of BCK2 or the overexpression of
BCK2. (A) a-Factor sensitivity. Equal numbers of exponentially growing cells
(about 1,000 cells, grown in SC-uracil or SC-leucine 2% glucose medium) of
strains CY3319 (Dbck2 {YCp50}), CY3317 and CY3318 (Dbck2 {BCK2/
YCp50}), CY3321 (Dbck2 {YEp13}), and CY3320 (Dbck2 {BCK2/YEp13})
were spotted onto YPD plates containing the indicated concentration of a-fac-
tor. All of the strains are transformants of strain CY3276. The plates were
incubated at 308C for the indicated times. WT, wild type. (B) Cell size. Shown are
Coulter Channelyzer plots (29) of cell volume distributions for cells growing
exponentially in SC-uracil 2% glucose medium at 308C. The strains were CY3319
(Dbck2 {YCp50}), CY3317 (Dbck2 {BCK2/YCp50}), and CY3368 (Dbck2
{BCK2/YEp24}). Strain CY3370 (Dbck2 {YEp24}) had a cell volume distribu-
tion indistinguishable from that of CY3319 (Dbck2 {YCp50}) (data not shown).
All of the strains are transformants of CY3276.
TABLE 2. Summary of genetic interactions of BCK2
Strain Growthrate
Plus high-
copy-
number
BCK2
Plus Dbck2
Dcln3 wta NDb Viable, but grows very slowlyc
Dcln1 wt ND No effect
Dcln2 wt ND No effect
Dcln1 Dcln2 Near wtd ND Slightly slower than Dcln1
Dcln2
Dcln2 Dcln3 Moderate Stimulates ND
Dswi4 Slow Stimulates Much slower than Dswi4
alonee
Dswi6 Slow No effect Lethalf
a wt, wild type.
b ND, not determined.
c Heterologous expression of CLN2 from either the S.p.ADH or the S.c.ADH
promoter stimulated the growth rate of bck2 cln3 strains to near wild-type levels.
d Both strains for this cross had SSD1-v genetic backgrounds because Dcln1
Dcln2 CLN3 ssd1-d strains grow very slowly (12).
e Heterologous expression of CLN2 from either the S.p.ADH or the S.c.ADH
promoter stimulated the growth rate of bck2 swi4 strains, but not quite to that of
swi4 strains.
f Heterologous expression of CLN2 from either the S.p.ADH or the S.c.ADH
promoter cured the lethality of bck2 swi6 strains, but the resulting strains did not
grow as well as swi6 strains.
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CLN2 was expressed from the S.p.ADH promoter (Fig. 4B).
Therefore, sequences upstream of the CLN2 start codon are
required for induction by overexpressed BCK2.
In vitro, SWI4/SWI6 complexes are the major factors that
bind to SCB elements, while MBP1/SWI6 complexes are the
major factors that bind to MCB elements (1, 2, 14, 22, 26, 38).
Recently, it has been shown that deletion of a 101-bp NruI-
SphI restriction fragment from the CLN2 promoter, which
removes or destroys three SCB-like sequences and two CGCG
core MCB-like sequences, causes a dramatic reduction in
CLN2 RNA levels (10, 36). We placed the NruI-SphI CLN2
promoter fragment into the D52-HIS4:lacZ reporter gene on
YCp50 (28). The D52 mutation removes the HIS4 upstream
activating sequences so that this reporter, without an insert,
gave 1 U of b-galactosidase activity, and pGAL:BCK2 had no
effect on these levels. In a control strain (no pGAL:BCK2), the
reporter containing the NruI-SphI CLN2 promoter fragment
was not activated when galactose was added to the culture
(Table 3). By contrast, in a pGAL:BCK2 strain, the reporter
containing the NruI-SphI CLN2 promoter fragment was acti-
vated 1.74-fold when galactose was added to the culture (Table
3). These findings suggest that BCK2-responsive elements are
at least partially within the NruI-SphI CLN2 promoter frag-
ment, which contains two intact SCB-like sequences and one
intact CGCG core MCB-like sequence.
To assay transcription from only SCB promoter elements,
we used a strain containing a lacZ reporter gene whose tran-
scription was activated by four synthetic SCB elements (SCB
sequence from the HO promoter [31]; strain provided by B.
Andrews). Relative to the control vector with no insert, over-
expression of SWI4 from the pGAL promoter greatly stimu-
lated transcription from the multiple synthetic SCB elements
(Fig. 5A). Overexpression of BCK2 also stimulated transcrip-
tion from the multiple synthetic SCB elements, to levels
slightly higher than those obtained from overexpression of
CLN3-1 (which encodes a hyperactive form of CLN3) and
modestly higher than those obtained from overexpression of
wild-type CLN3 (by 4 h, pGAL:CLN3 gives 75 U [data not
shown]). Therefore, like overexpressed CLN3 or CLN3-1,
overexpressed BCK2 can induce transcription from SCB ele-
ments.
Overexpressed BCK2 might activate transcription from the
multiple synthetic SCB elements indirectly. For instance, over-
expressed BCK2 might activate the expression of CLN1 or
CLN2 via a non-SCB promoter element, and the higher levels
of CLN1 and CLN2 would then activate transcription from the
multiple synthetic SCB elements (the same argument is also
possible for the activation of SCB elements by overexpressed
CLN3). If overexpressed BCK2 activates CLN1 or CLN2 ex-
pression, which in turn activates SCB-driven transcription,
then overexpression of CLN1 or CLN2 from the pGAL pro-
moter should induce SCB-driven transcription. Neither pGAL:
CLN1 (Fig. 5A) nor pGAL:CLN2 (data not shown) caused an
increase in the b-galactosidase levels expressed from a lacZ
gene whose transcription is driven by multiple synthetic SCB
elements. Therefore, in this assay, overexpressed CLN3, but
not CLN1 or CLN2, activated SCB-dependent transcription.
These findings suggest that CLN1 and CLN2 are not nearly as
effective as CLN3 for activating SCB-dependent transcription.
In addition, we looked at the ability of overexpressed BCK2 to
activate transcription from the multiple synthetic SCB ele-
ments in the absence of SWI4 or SWI6. Unlike transcription
from the CLN1 and CLN2 promoters (which are transcribed at
low levels in the absence of SWI4 [10, 31, 36]), transcription
from the promoter containing multiple synthetic SCB elements
is completely SWI4 dependent (in the presence of SWI6) or
FIG. 4. Overexpressed BCK2 can activate CLN1, CLN2, and CLB5 tran-
scription. (A) Strains CY3507 (pGAL:BCK2/YCp50) and CY3510 (YCp50/
pGAL expression plasmid with no insert) were grown exponentially at 308C on
SC-uracil 2% raffinose medium. Both strains are transformants of strain AY925
(which contains a wild-type [WT] BCK2 gene). At an OD600 of 0.20, galactose
was added to 2% (final concentration), and cells were collected at the indicated
times. (B) Strains CY3507 and CY3510 were transformed with a LEU2/cen
plasmid containing the S.p.ADH:CLN2 gene. The S.p.ADH:CLN2 gene gives a
CLN2 RNA shorter than the wild-type CLN2 RNA because it is missing about
100 bases of 59 CLN2 RNA sequences. The strains were grown exponentially at
308C on SC-uracil,-leucine 2% raffinose medium. At an OD600 of 0.20, galactose
was added to 2% (final concentration), and cells were collected at the indicated
times. cont., control. For both panels, total RNA was prepared and Northern
analysis was performed as described in Materials and Methods.
TABLE 3. Overexpressed BCK2 can activate transcription
from a CLN2 promoter fragmenta
Strain
b-Galactosidase activity (U)b
Ratioc
Raffinose 1Galactose
Control 53 (8.3) 52 (1) 0.98
pGAL:BCK2 46 (4.5) 80 (7.2) 1.74
a All strains were transformants of AY925 that contained the D52-HIS4:lacZ/
YCp50 reporter plasmid (28) containing the NruI-SphI CLN2 promoter frag-
ment in the wild-type orientation and either a control plasmid or a pGAL:BCK2
plasmid (LEU2 marker). The reverse orientation of the CLN2 promoter frag-
ment gave 1.84-fold induction with pGAL:BCK2 and 0.99-fold induction with the
control plasmid. The transformants were grown exponentially at 308C on SC-
uracil-leucine 2% raffinose medium. At time zero, galactose was added to 2%
(final concentration), and the cultures were grown for 4 h. Whole cell extracts
were prepared and b-galactosidase assays were performed as described in Ma-
terials and Methods.
b Standard deviations (from three or four independent assays) are in paren-
theses.
c Units on galactose divided by units on raffinose.
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SWI6 dependent (in the presence of SWI4) (Fig. 5B and C).
Moreover, overexpression of BCK2 (or CLN3 or CLN3-1)
cannot bypass the requirement of SWI4 or SWI6 for the acti-
vation of transcription from the multiple synthetic SCB ele-
ments (Fig. 5B and C) (overexpressed BCK2 did not give any
induction of the low SWI4- or SWI6-independent expression of
1 U).
Because the CLN1 and CLN2 promoters also contain core
MCB-like CGCG elements (SWI4 can bind in vitro to MCB
elements [22]) and because overexpressed BCK2 was also able
to stimulate the transcription of CLB5 (whose promoter con-
tains MCB-like elements [17]), we determined the ability of
overexpressed BCK2 to stimulate transcription from a pro-
moter containing four synthetic MCB elements (plasmid
pBA487 in reference 41; provided by B. Andrews). Interest-
ingly, overexpressed BCK2 stimulated expression from the
multiple synthetic MCB elements, and this stimulation was
completely dependent on SWI6 (Fig. 5D). Overexpression of
CLN2 (from the GAL1 promoter) was not able to stimulate
MCB-dependent expression in this assay (data not shown).
Therefore, the ability of overexpressed BCK2 to stimulate
transcription from the multiple synthetic MCB elements is not
due to the increased levels of CLN2 RNA.
Roles of SWI4 and SWI6 in BCK2-induced transcription
from promoters containing SCB-like and MCB-like elements.
In contrast to the promoter containing the multiple synthetic
SCB elements (whose transcription is completely SWI4 or
SWI6 dependent), the CLN1 and CLN2 promoters are ex-
pressed at low levels in the absence of SWI4 or in the absence
of SWI6. Interestingly, some of the transcriptional activation of
CLN1, CLN2, and HCS26 (an additional cyclin whose pro-
moter contains SWI4/SWI6 binding sites [31]) by overex-
pressed BCK2 was not dependent on SWI4 (in the presence of
SWI6) or dependent on SWI6 (in the presence of SWI4). The
fold induction by overexpressed BCK2 was similar for the
Dswi4 or Dswi6 strain compared with the wild-type strain. How-
ever, overexpressed BCK2 induced CLN1, CLN2, and HCS26
to higher levels in the presence of SWI4 and SWI6 (Fig. 6) (the
FIG. 5. Overexpressed BCK2 can activate transcription from SCB and MCB promoter elements. (A to C) Strains CY3557 (wild type), CY3582 (Dswi4), and CY3656
(Dswi6) were isogenic and contained the lacZ gene under the control of four tandem synthetic SCB elements integrated at the HIS3 locus, termed his3D124lacZ (31).
These strains were transformed with the indicated URA3/cen pGAL expression plasmid. The transformants were grown exponentially at 308C on SC-uracil 2% raffinose
medium, and at time zero, galactose was added to 2% (final concentration). (D) Strains CY3798 (wild type [wt]) and CY3779 (Dswi6), both isogenic and containing
a 2mm URA3 plasmid with the lacZ gene under the control of four tandem synthetic MCB elements (41), were transformed with the indicated LEU2/cen pGAL
expression plasmid. The transformants were grown exponentially at 308C on SC-uracil,-leucine 2% raffinose medium, and at time zero, galactose was added to 2% (final
concentration). For all panels, extracts were prepared and b-galactosidase assays were performed as described in Materials and Methods.
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level of induction of the GAL1 promoter is not as high for the
isogenic wild-type, Dswi4, and Dswi6 strains used for Fig. 5 and
6 as for the strains used in Fig. 4; note also that the level of
CLN2 induction was lower for the strains in Fig. 6 than for
those in Fig. 4).
Therefore, although maximal stimulation of CLN1 and
CLN2 transcription by overexpressed BCK2 required SWI4 or
SWI6, some of the overexpressed BCK2-induced levels of
CLN1 and CLN2 RNA resulted from either a promoter ele-
ment that is normally SWI4 or SWI6 independent (an element
unrelated to SCB or MCB elements to which SWI4 and SWI6
would not interact) or from a SWI4- or SWI6-independent
mode of activation through promoter elements that are nor-
mally largely SWI4 or SWI6 dependent (such as SCB- or
MCB-like elements). If the stimulation of CLN1 and CLN2
expression by overexpressed BCK2 is due to promoter ele-
ments that are normally largely SWI4 or SWI6 dependent,
overexpressed BCK2 would have to function differently at the
natural CLN1 and CLN2 SCB-like and MCB-like elements
compared with the multiple synthetic SCB and MCB elements
(where activation by overexpressed BCK2 is completely SWI4
or SWI6 dependent [Fig. 5]).
Overexpression of BCK2 in wild-type strains also stimulated
CLB5 expression and RNR1 (16) expression, and this stimula-
tion was completely independent of SWI4 (Fig. 4, Fig. 6, and
data not shown). Both the CLB5 promoter (17) and the RNR1
promoter (15a) contain multiple MCB-like sequences. Normal
periodic transcription of certain MCB-driven genes requires
both MBP1 and SWI6 (14, 22, 25, 27). MBP1 is a SWI4-related
transcription factor that binds, in a complex with SWI6, to
MCB promoter elements (22). In a Dswi6 strain, the normal
length RNR1 RNA is reduced in abundance, while a longer
RNR1 RNA is present (Fig. 6) (because this length change is
small, we include two panels for RNR1, each from a different
gel). This effect of a swi6 mutation on RNR1 RNA has been
seen previously (14). Importantly, overexpression of BCK2
stimulated RNR1 expression in the absence of SWI6, and this
BCK2-induced RNR1 RNA had a normal or very near normal
length (Fig. 6). This SWI6-independent stimulation of RNR1
transcription is not due to the ability of overexpressed BCK2 to
stimulate MBP1 RNA levels (Fig. 6) (in these cultures, the
overall MBP1 RNA levels are independent of SWI4 or SWI6
[Fig. 6] and do not vary in the cell cycle [22]).
We also determined the effect of overexpressed BCK2 on
CLB2 expression. CLB2, which encodes a B-type cyclin, is
expressed during S and G2 phases (20, 32). Overexpression of
BCK2 increased CLB2 RNA levels in a wild-type strain (Fig.
6). The levels of CLB2 RNA were low for the Dswi4 cells,
possibly because the culture is enriched in G1 cells as a result
of the defect in CLN1 and CLN2 expression. Interestingly,
overexpression of BCK2 in a Dswi4 strain or a Dswi6 strain (but
not a wild-type strain) stimulated the expression of a shorter
CLB2 RNA (Fig. 6). The nature of the CLB2 promoter ele-
ment responsible for this effect is not known.
For the CLN2 promoter, the UAS2 region is required for
maximal induction by overexpressed BCK2. Overexpressed
BCK2 caused about a twofold activation of transcription from
the CLN2 NruI-SphI promoter fragment, which contains two
intact SCB-like sequences and one intact CGCG core MCB-
like sequence (Table 3). This fold activation is similar to the
approximately twofold activation of multiple synthetic SCB or
MCB elements by overexpressed BCK2 (Fig. 5). By contrast,
for the chromosomal CLN1 and CLN2 genes in the W303
strain background (Fig. 4A), overexpressed BCK2 increased
the RNA levels much more than twofold.
To determine the CLN2 promoter sequences that are re-
sponsible for this greater activation by overexpressed BCK2,
we prepared CLN2 promoter deletions (Fig. 7A). The
CLN2-AA gene lacks sequences upstream of the NruI site,
which removes or destroys potential MCB CGCG core ele-
ments at 2644 and 2603 and the SCB-like element at 2603.
Compared with the chromosomal CLN2 gene, CLN2-AA on
the LEU2/cen plasmid gave about twofold-lower levels of
CLN2 RNA when BCK2 was overexpressed (Fig. 7B and data
not shown). When UAS1 was also absent (CLN2-BB), the level
of CLN2 expression was extremely low and was no longer
FIG. 6. Roles of SWI4 and SWI6 in BCK2-induced transcription. Isogenic
strains CY3574 (wild type [WT], YCp50/pGAL expression plasmid with no
insert), CY3575 (wild type, pGAL:BCK2/YCp50), CY3594 (Dswi4, YCp50/pGAL
expression plasmid with no insert), CY3595 (Dswi4, pGAL:BCK2/YCp50),
CY3671 (Dswi6, YCp50/pGAL expression plasmid with no insert), and CY3672
(Dswi6, pGAL:BCK2/YCp50) were grown exponentially at 308C on SC-uracil 2%
raffinose medium. Strains CY3574 and CY3575 are transformants of CY3557,
strains CY3594 and CY3595 are transformants of CY3582, and strains CY3671
and CY3672 are transformants of CY3656. At an OD600 of 0.20, galactose was
added to 2% (final concentration), and the cells were collected at the indicated
times. Total RNA was prepared and Northern analysis was performed as de-
scribed in Materials and Methods. Because the gel only had 20 lanes, identical
Dswi4 samples were loaded onto two separate gels, so that the RNA levels of the
Dswi6 cells can be directly compared with those in the Dswi4 cells and, by
comparison with the other gel, with those in the wild-type cells. Like ACT1, the
URA3 RNA lengths and levels were not affected by overexpression of BCK2
(data not shown).
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increased by overexpressed BCK2 (Fig. 7B). Therefore, acti-
vation of CLN2 transcription by overexpressed BCK2 requires
promoter elements within UAS1 (probably the SCB-like and
MCB-like sequences). Also, UAS2 (36) by itself is not suffi-
cient for activation by overexpressed BCK2.
We also determined if UAS2 sequences or other sequences
downstream of UAS1 could modulate the ability of BCK2 to
induce transcription from UAS1. The activation of CLN2-DD
and CLN2-EE transcription by overexpressed BCK2 was sim-
ilar to that of CLN2-AA (Fig. 7C). By contrast, the absence of
UAS2 sequences (CLN2-CC) caused a substantial reduction in
the ability of overexpressed BCK2 to induce CLN2 transcrip-
tion (Fig. 7C). Therefore, sequences contained in the UAS2
region are required for maximal induction of CLN2 transcrip-
tion by overexpressed BCK2.
Relationship of BCK2 to PKC1 and MPK1. The BCK2 gene
was originally isolated by its ability, when present on a high-
copy-number plasmid, to suppress the temperature-sensitive
phenotype of a Dmpk1 strain (24). MPK1 encodes a mitogen-
activated protein kinase homolog that functions downstream
of the protein kinase C homolog encoded by the PKC1 gene.
That overexpression of BCK2 stimulated CLN1 and CLN2
expression raised the possibility that the suppression of a
Dmpk1 strain by BCK2 was due to the ability of BCK2 to
stimulate G1 cyclin expression. Although the BCK2 gene on a
high-copy-number plasmid suppressed, neither normal-level
(S.p.ADH:CLN2) or high-level (S.c.ADH:CLN2) heterologous
expression of CLN2 (Fig. 8A) nor high-copy-number MBP1
(data not shown) suppressed the temperature-sensitive pheno-
type of the Dmpk1 strain. We suggest that high-copy-number
BCK2 suppresses a Dmpk1 strain by stimulating the expression
of some gene(s) other than CLN1 and CLN2. In addition,
although high-copy-number BCK2 partially suppressed the
temperature-sensitive phenotype of an mpk1 strain (and also
partially suppressed the slow-growth-rate phenotype at 248C),
neither CLN3 nor CLN3-1 on a high-copy-number plasmid
suppressed the Dmpk1 strain (data not shown). Therefore,
FIG. 7. CLN2 promoter sequences required for activation by overexpressed
BCK2. (A) The CLN2 promoter sequences present in each deletion (see Mate-
rials and Methods) are indicated by a horizontal line. All numbers are relative to
the A of the predicted CLN2 ATG initiation codon. UAS1 and UAS2 of Stuart
and Wittenberg (36) are shown. The NruI site is at position 2601, and the SphI
site is at position 2505. For the three indicated SCB-like elements, the element
at position 2603 has a 6-of-8-bp (6/8), the element at position 2578 has a 7/8,
and the element at position 2526 has a 7/8 match to the HO consensus SCB
sequence CACGAAAA. However, additional possible SCB-like sequences with
a 6/8 match to the SCB consensus sequence are present in the CLN2 promoter
(forward orientation 6/8 sequences occur at positions 2621, 2615, 2526, 2361,
and 2355, while reverse orientation 6/8 sequences occur at positions 2471,
2403, and 2302). (B) In the absence of sequences upstream of the SphI site
(2505), CLN2 RNA levels are extremely low and are not induced by overex-
pressed BCK2. The wild-type (WT) chromosomal CLN2 strain (CY3507) was
grown on SC-uracil 2% raffinose medium. The strains containing CLN2 ex-
pressed from promoters AA or BB (in either orientation on a LEU2/cen plasmid;
see Materials and Methods) are isogenic to CY3507 except that they also have a
near complete deletion of chromosomal CLN2 coding sequences (CY4271). The
strains containing CLN2 expressed from the AA or BB promoters were grown on
SC-uracil,-leucine 2% raffinose medium. Cells, grown at 308C, were collected just
prior to (2) or 55 min after (1) the addition of galactose to 2% (final concen-
tration). The CLN2 RNAs expressed from the CLN2 AA and BB promoters are
slightly longer than wild-type CLN2 RNA because the CLN2 promoter deletions
were prepared by using a CLN2 gene with sequences encoding a triple hemag-
glutinin epitope tag at the carboxyl terminus (CLN2C in reference 39). The
CLN2 panel is overexposed to show the very low levels of CLN2 RNA expressed
from the BB promoter. (C) The UAS2 region is required for maximal activation
of CLN2 by overexpressed BCK2. CLN2 was expressed from promoter AA, CC,
DD, or EE (on a LEU2/cen plasmid) in strain CY4271. The strains were grown
at 308C in SC-uracil,-leucine 2% raffinose medium. Cells were collected just prior
to (2) or 55 min after (1) the addition of galactose to 2% (final concentration).
FIG. 8. Genetic interactions of BCK2 with SIT4 and MPK1. (A) Low- or
high-level heterologous expression of CLN2 does not cure the temperature-
sensitive phenotype of a Dmpk1 strain. Strain CY3182 (Dmpk1) was transformed
with the indicated plasmids. Transformants were patched onto SC-uracil 2%
glucose plates, grown for 1 day at 248C, and replica plated onto YPD plates.
Growth is shown after 1.5 days at 378C. (B) Unlike Dcln3 Dsit4 SSD1-v strains,
which are nearly inviable, Dbck2 Dsit4 SSD1-v strains grow at the same rate as
Dsit4 SSD1-v strains. Strain CY3276 (Dbck2 SSD1-v) was crossed to strain CY279
(Dsit4 SSD1-v), and representative progeny (from 20 tetrads) of the indicated
genotype were streaked onto YPD plates. Growth is shown after 4.5 days at 308C.
WT, wild type. (C) A model of BCK2 function relative to that of CLN3 and SIT4.
The placement of SIT4 upstream of BCK2 is arbitrary.
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although BCK2 and CLN3 can each separately activate CLN1
and CLN2 transcription, only BCK2 would be able to stimulate
the transcription of the putative gene(s) that suppresses the
defects of an mpk1 strain.
Relationship of BCK2 to SIT4. We isolated mutations that
result in lethality or cause a very slow growth rate in the
absence of CLN3 in order to obtain genes that function in the
SIT4 pathway for the activation of CLN1 and CLN2 expres-
sion. The absence of both the SIT4 pathway and the CLN3
pathway for the activation of CLN1 and CLN2 expression
results in an extremely slow-growth phenotype (7 days for a sit4
cln3 strain to form microcolonies) that is due to a defect in
CLN1 and CLN2 expression (the synthetic growth defect is
completely cured by heterologous expression of CLN2 from
the S.p.ADH promoter) (19). The absence of both the BCK2
pathway and CLN3 pathway for the activation of CLN1 and
CLN2 expression also results in a slow-growth phenotype that
is due to a defect in CLN1 and CLN2 expression. If BCK2
functions within the SIT4 pathway for the activation of CLN1
and CLN2 expression, then a Dbck2 Dsit4 strain should not
grow any more slowly than a Dsit4 strain (viability of Dsit4
strains requires SSD1-v genetic backgrounds [19, 37]). If, like
CLN3, BCK2 functions in a pathway parallel to SIT4 for the
activation of CLN1 and CLN2 expression, then a Dbck2 Dsit4
strain (like a Dcln3 Dsit4 strain) should grow much more slowly
than a Dsit4 strain. From a cross of a Dbck2 strain to a Dsit4
strain, the Dbck2 Dsit4 progeny grew at the same rate as the
Dsit4 progeny (Fig. 8B). This finding suggests that BCK2 and
CLN3 activate CLN1 and CLN2 expression by different path-
ways and that BCK2 may function within the SIT4 pathway for
the activation of CLN1 and CLN2 expression (Fig. 8C). Con-
sistent with this model is the finding that, like a Dsit4 Dswi6
strain which is inviable (19), a Dbck2 Dswi6 strain is also invi-
able (Table 2). Because a Dsit4 strain accumulates CLN1 and
CLN2 RNA at a rate much slower than that of a Dbck2 strain,
the pathway proposed in this model cannot be linear but must
include factors in addition to BCK2 within the SIT4 pathway.
DISCUSSION
Cells containing a deletion of either the BCK2 gene or the
CLN3 gene have a modest defect in CLN1 and CLN2 expres-
sion that causes the cells to be more sensitive to a-factor and
to execute Start at a larger than normal cell volume. Therefore,
BCK2 and CLN3 have similar effects on Start regulation. The
defect in CLN1 and CLN2 expression in the absence of either
BCK2 or CLN3 is modest: the cells have a wild-type growth
rate, and the levels of CLN1 and CLN2 RNA increase to near
normal levels during late G1, but with a modest delay. There-
fore, in the absence of CLN3, BCK2 (BCK2 RNA levels do not
vary in the cell cycle [12a]) can effectively activate the periodic
expression of CLN1 and CLN2 during late G1. Likewise, in the
absence of BCK2, CLN3 (CLN3 RNA levels vary two- to
threefold during the cell cycle [19]) can effectively activate the
periodic expression of CLN1 and CLN2 during late G1. How-
ever, in the absence of both BCK2 and CLN3, the cells cannot
effectively accumulate CLN1 and CLN2 RNAs during late G1.
This defect in CLN1 and CLN2 RNA expression is so severe
that it causes Dbck2 Dcln3 cells to have a slow growth rate.
In contrast to Dbck2 Dcln3 cells, Dbck2 Dcln1 cells and
Dbck2 Dcln2 cells grow at about the same rate as wild-type
strains (reference 18 and Table 2). Moreover, Dbck2 Dcln1
Dcln2 strains grow only slightly more slowly than Dcln1 Dcln2
strains (Table 2). Although a cell is viable if it has any one of
the three CLN genes (CLN1, CLN2, or CLN3) (33), the CLN
genes are not equivalent. Unlike CLN3, the normal expression
of CLN1 and CLN2 requires SWI4, SWI6, and SIT4 (19, 30,
31). Moreover, CLN3 has been proposed to be a regulator of
Start via its effects on the accumulation of CLN1 and CLN2
RNA levels (39). Whether or not CLN3 can mediate Start
directly (in which case the CLN3/CDC28 complex would phos-
phorylate the same Start substrates as the CLN1/CDC28 and
CLN2/CDC28 complexes) is not currently known.
There are two possible explanations for the near normal
growth rate of bck2 cln1 cln2 cells in contrast to the very slow
growth rate of bck2 cln3 cells. For the first explanation, CLN3
can directly activate Start. In this case, in the absence of CLN1,
CLN2, and BCK2 (BCK2 is not required for CLN3 expression
[data not shown]), CLN3 would mediate the direct activation
of Start. For the other explanation, CLN3 cannot directly ac-
tivate Start but is a regulator of the expression of CLN1, CLN2,
and other G1 cyclins that are the direct activators of Start (39).
In this case, CLN3, compared with CLN1 and CLN2, would be
a much more potent activator of the expression of CLN1 and
CLN2 and other G1 cyclins. In the absence of the BCK2 acti-
vation pathway, CLN3 becomes almost essential for activating
the expression of CLN1, CLN2, and other G1 cyclin genes.
The late G1 activation of CLN1 and CLN2 expression is due
to multiple pathways. The major pathway for the activation of
the CLN1 and CLN2 promoters is via SWI4 (10, 31, 36). SWI4
most likely binds to SCB-like and possibly MCB-like elements
in the CLN1 and CLN2 promoters (22, 31). Because the great
majority of CLN1 and CLN2 transcription is SWI4 dependent,
BCK2 (at normal levels) is required in the absence of CLN3
for the SWI4-dependent activation of CLN1 and CLN2 tran-
scription during late G1.
Another way to assay the function of BCK2 is via the effects
due to its overexpression. Overexpression of BCK2 greatly
stimulates CLN1, CLN2, and HCS26 expression (the extent of
CLN2 induction is strain dependent; compare Fig. 4 and 6).
Overexpressed BCK2 also stimulates CLB5, RNR1, SWI4, and
CLB2 expression, but to a lesser extent. For these genes, a
large fraction of the BCK2-induced RNA levels is dependent
on either SWI4 or SWI6. However, in the absence of SWI4 (in
the presence of SWI6) or in the absence of SWI6 (in the
presence of SWI4), overexpression of BCK2 is still able to
increase the levels of CLN1, CLN2, and HCS26 RNAs, sug-
gesting that BCK2 can also induce CLN1, CLN2, and HCS26
transcription by a SWI4-independent mechanism (in the pres-
ence of SWI6) or by a SWI6-independent mechanism (in the
presence of SWI4).
Unlike the reporter gene containing multiple synthetic SCB
elements (whose expression is completely SWI4-dependent
and cannot be induced by overexpressed BCK2 in the absence
of SWI4), CLN1 and CLN2 have SWI4-independent pathways
of transcriptional activation (they are transcribed at low levels
in the absence of SWI4 [references 10 and 36 and Fig. 6]). It
has been reported that the SWI4-independent expression of
CLN2 is dependent on MBP1, that MBP1 can bind in vitro to
SCB elements, and that SWI4 can bind in vitro to MCB ele-
ments (22). MBP1 might be able to activate CLN1 and CLN2
transcription via the SCB-like or MCB-like elements present in
these promoters (but MBP1 cannot activate transcription from
the promoter containing multiple synthetic SCB elements).
One possibility is that the ability of overexpressed BCK2 to
stimulate CLN1, CLN2, and HCS26 transcription in the ab-
sence of SWI4 (but to lower levels than when SWI4 is present)
is due to the ability of BCK2 to stimulate MBP1-dependent
activation from the SCB-like and/or MCB-like elements
present in these promoters. Alternatively, overexpressed
BCK2 might be able to stimulate CLN1 and CLN2 transcrip-
tion via two different types of promoter elements; one type
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would be an SCB- or MCB-like SWI4/SWI6/MBP1-dependent
element, and a second type would be a non-SCB/MCB-related
element (which would be present in the CLN1, CLN2, and
HCS26 promoters).
A large fraction of the expression of CLN1 and CLN2 during
late G1 is dependent on SWI4 and, for CLN2, requires the
SCB-like and/or MCB-like elements present in the CLN2 pro-
moter (10, 30, 31, 36). Therefore, in the absence of CLN3,
normal levels of BCK2 are required for the SWI4-dependent
expression of CLN1 and CLN2, possibly for regulating SWI4’s
ability to activate transcription via SCB-like and/or MCB-like
elements. The large activation of CLN2 transcription by over-
expressed BCK2 seems to be due to two pathways; one path-
way is the about twofold induction inherent within UAS1
(probably via the SCB- and MCB-like elements), a second
pathway is via the ability of UAS2 to modulate activation by
UAS1. It is not known if the sequences within UAS2 through
which BCK2 modulates activation by UAS1 are the same se-
quences that give UAS2 the ability, by itself, to very weakly
activate transcription during late G1 (36).
Overexpression of BCK2 also stimulates the transcription of
CLB5 and RNR1, two genes suggested to be activated by MCB-
like elements, and the transcription of a promoter containing
multiple synthetic MCB elements. In vitro, the major binding
activity to MCB elements is due to MBP1/SWI6 complexes
(22). In a Dswi6 strain, in which the normal length RNR1 RNA
is reduced in abundance while a lower amount of a longer
RNR1 RNA is present, overexpression of BCK2 stimulates the
transcription of the normal- or near-normal-length RNR1
RNA. Therefore, at the RNR1 promoter, overexpressed BCK2
can substitute for the function of SWI6. A model whereby
BCK2 would regulate the function of both SWI4- and MBP1-
containing complexes to modulate transcription at SCB-like
and MCB-like elements is consistent with our findings. How-
ever, BCK2 may also be able to activate transcription from
sequences other than SCB/MCB-like elements. The effect of
overexpressed BCK2 on CLB2 expression in the absence of
SWI4 or SWI6 cannot be interpreted within this model until
more is known about the factors that regulate the periodic
transcription of CLB2. Interestingly, although the CLB2 pro-
moter region does not contain apparent SCB elements, it does
contain two CGCG core MCB-like sequences at 2827 and
2660.
BCK2 has been isolated previously by two different suppres-
sion schemes. In one scheme, high-copy-number BCK2 was
isolated by its ability to suppress the temperature-sensitive
phenotype of a Dmpk1 strain (24). Because low- or high-level
heterologous expression of CLN2 did not cure the tempera-
ture-sensitive phenotype of the Dmpk1 strain, we suggest that
overexpression of BCK2 suppresses the temperature-sensitive
phenotype of a Dmpk1 strain by stimulating the expression of
some gene(s), other than G1 cyclin genes, whose expression is
defective in the absence of MPK1 or whose increased expres-
sion can bypass MPK1 function.
BCK2 was also isolated by its ability, on low- or high-copy-
number plasmids, to suppress the lethality due to the absence
of CLN1, CLN2, and CLN3 function (18, 20a). One possibility
is that overexpressed BCK2 can activate the expression of
additional cyclins (such as HCS26) that can substitute for the
function of CLN1, CLN2, and CLN3. Alternatively, because
overexpressed BCK2 can stimulate the expression of two dif-
ferent MCB-driven genes (CLB5 and RNR1) and the expres-
sion driven by multiple synthetic MCB elements, overex-
pressed BCK2 might be able to bypass CLN function for the
activation of MCB-driven genes.
We isolated bck2 mutations because BCK2 is required for
significant CLN1 and CLN2 transcription in the absence of
CLN3. The accumulation of CLN1 and CLN2RNA during late
G1 probably functions as an integrator of growth and mating
signals from various sources. Proteins such as FAR1 are in-
duced by the a-factor pathway to repress the accumulation of
CLN1 and CLN2 (6, 7). Because the CLN3 protein is very low
in abundance and is unstable (9, 40), the levels of CLN3 might
reflect the rate of protein synthesis. As such, CLN3 could set
the rate of CLN1 and CLN2 RNA accumulation, and hence
the timing of Start, relative to the rate of protein synthesis (39).
Like CLN3, BCK2 can also activate CLN1 and CLN2 expres-
sion, and the importance of BCK2 for Start is uncovered when
the cells lack the CLN3 activation pathway. It remains to be
determined what growth signals, if any, regulate the ability of
BCK2 to stimulate G1 cyclin accumulation.
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